Últimas noticias sobre ProAssurance (NYSE:PRA) Bolsa

PROASSURANCE CORP

ProAssurance

ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

Five,Below,Now,Open,-,Closeup,Of,Sign,On,Building

AGMH

AKBA

BHIL

DEVS

EFXT

FIVE

IOBT

MAZE

MHUA

OPTN

RVSB

VRPX

ZCAR

Las acciones de Five Below se disparan tras superar expectativas. Conoce otros grandes movimientos bursátiles en el premercado de EE.UU.

Las acciones de Five Below (FIVE) suben un 12%; Aquí están 20 acciones que se mueven en premercado

News

General

ProAssurance Receives Shareholders' Approval For Its Proposed Acquisition By The Doctors Company

Piper Sandler analyst Paul Newsome maintains ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) with a Neutral and raises the price target from $18 to $25.

Price Target

Analyst Ratings

Piper Sandler Maintains Neutral on ProAssurance, Raises Price Target to $25

ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.20 by 35 percent. This is a 62.5 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $236.28 million which missed the analyst consensus estimate of $305.47 million by 22.65 percent. This is a 3.23 percent decrease over sales of $244.15 million the same period last year.

Earnings

Earnings Misses

ProAssurance Q1 Adj. EPS $0.13 Misses $0.20 Estimate, Sales $236.28M Miss $305.47M Estimate

As of April 14, 2025, two stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Palomar Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLMR#NASDAQ">PLMR</a>)</h3>
<ul>
<li>On April 11, Jefferies analyst Andrew Andersen maintained Palomar with a Buy and raised the price target from $145 to $168. The company's stock jumped around 17% over the past five days and has a 52-week high of $148.54 .</li>
<li>RSI Value: 71.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>PLMR Price Action: Shares of Palomar gained 3.4% to close at $147.88 on Friday.</li>
<li>Edge Stock Ratings: 97.47 Momentum score with Value at 46.88. </li>
</ul>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/plmr"><img loading="lazy" decoding="async" width="493" height="186" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/14044044/image-92.png" alt="" class="wp-image-869621" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/14044044/image-92.png 493w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/14044044/image-92-300x113.png 300w" sizes="(max-width: 493px) 100vw, 493px" /></a></figure>
<h3 class="wp-block-heading">ProAssurance Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>)</h3>
<ul>
<li>On April 3, Citizens Capital Markets analyst Matthew Carletti downgraded ProAssurance from Market Outperform to Market Perform. The company's stock gained around 48% over the past month and <a href="https://www.benzinga.com/quote/PRA">has a 52-week high</a> of $23.70.</li>
<li>RSI Value: 83.2</li>
<li>PRA Price Action: Shares of ProAssurance gained 0.7% to close at $23.30 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Heritage Insurance Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRTG#NYSE">HRTG</a>)</h3>
<ul>
<li>On March 13, Citizens Capital Markets analyst Matthew Carletti reiterated Heritage Insurance with a Market Perform rating. The company's stock gained around 16% over the past five days and has a<a href="https://www.benzinga.com/quote/HRTG"> 52-week high </a> of $16.90.</li>
<li>RSI Value: 72.5</li>
<li>HRTG Price Action: Shares of Heritage Insurance gained 0.6% to close at $16.23 on Friday.</li>
</ul>
Curious about other BZ Edge Rankings? Click here to discover <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">how similar stocks measure up</a>. 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/04/44759831/top-3-industrials-stocks-that-may-explode-in-april">Top 3 Industrials Stocks That May Explode In April</a> </li>
</ul>
Photo via Shutterstock

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

HRTG

PLMR

Top 3 Financial Stocks That May Crash This Month

U.S. stocks settled lower on Friday, with the Dow Jones index tumbling over 2,200 points during the session.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst&#8217;s opinion to trust.
Benzinga&#8217;s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. One of the ways traders can sort through Benzinga&#8217;s extensive database of analyst ratings is by analyst accuracy. Here&#8217;s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock</a> Ratings.
Analyst: Mark Hughes
<ul>
<li>Analyst Firm: Truist Securities</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Maintained a Buy rating on W. R. Berkley Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) and increased the price target from $68 to $80 on April 3. This analyst sees around 25% upside in the stock.</li>
<li>Recent News: On April 1, W. R. Berkley named Michael G. MacMullin President of Berkley Luxury Group.</li>
</ul>
Analyst: Matthew Carletti
<ul>
<li>Analyst Firm: Citizens Capital Markets</li>
<li>Ratings Accuracy: 84%</li>
<li>Latest Rating: Downgraded rating on ProAssurance Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) from Market Outperform to Market Perform on April 3.</li>
<li>Recent News: On March 19, ProAssurance announced it will be acquired by The Doctors Company for $25.00 per share in cash.</li>
</ul>
Analyst: Zachary Fadem 
<ul>
<li>Analyst Firm: Wells Fargo</li>
<li>Ratings Accuracy: 84%</li>
<li>Latest Rating: Maintained an Overweight rating on RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) and slashed the price target from $375 to $300 on April 3. This analyst sees around 76% upside in the stock.</li>
<li>Recent News: On April 2, RH reported fourth-quarter financial results and missed its adjusted EPS and revenue estimates.</li>
</ul>
Analyst: Paul Newsome
<ul>
<li>Analyst Firm: Piper Sandler</li>
<li>Ratings Accuracy: 84%</li>
<li>Latest Rating: Maintained an Overweight rating on The Hanover Insurance Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THG#NYSE">THG</a>) and increased the price target from $190 to $205 on April 1. This analyst sees around 35% upside in the stock.</li>
<li>Recent News: On April 3, The Hanover appointed Richard W. Lavey as Chief Operating Officer.</li>
</ul>
Analyst: Josh Sullivan
<ul>
<li>Analyst Firm: Benchmark</li>
<li>Ratings Accuracy: 83%</li>
<li>Latest Rating: Maintained a Buy rating on TAT Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TATT#NASDAQ">TATT</a>) and increased the price target from $30 to $35 on April 3. This analyst sees around 37% upside in the stock.</li>
<li>Recent News: On March 26, TAT Technologies reported a year-over-year increase in fourth-quarter financial results.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44665280/how-to-earn-500-a-month-from-walgreens-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Walgreens Stock Ahead Of Q2 Earnings</a> </li>
</ul>
Photo via Shutterstock

TATT

5 Stock Picks Last Week From Wall Street's Most Accurate Analysts

Citizens Capital Markets analyst Matthew Carletti downgrades ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) from Market Outperform to Market Perform.

Downgrades

Citizens Capital Markets Downgrades ProAssurance to Market Perform

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday.
The Dow traded up 0.63% to 42,230.78 while the NASDAQ climbed 0.81% to 17,894.89. The S&amp;P 500 also rose, gaining, 0.61% to 5,710.13.
Check This Out: <a href="https://www.benzinga.com/25/03/44414809/tesla-to-450-here-are-10-top-analyst-forecasts-for-thursday">Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday</a>
Leading and Lagging Sectors Communication services shares rose by 1.4% on Thursday.
In trading on Thursday, consumer staples shares fell by 0.1%.
Top Headline
U.S. initial jobless claims increased by 2,000 to 223,000 during the second week of March, compared to market estimates of 224,000.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>ProAssurance Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) shares shot up 48% to $22.99 after the company announced it will be acquired by The Doctors Company for $25.00 per share in cash.</li>
<li>Shares of Windtree Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>)got a boost, surging 71% to $2.8950 after the company entered a license and supply agreement to become a sourcing partner for Evofem Biosciences for Evofem&#8217;s PHEXXI.</li>
<li>OptiNose, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTN#NASDAQ">OPTN</a>) shares were also up, gaining 55% to $9.28 after Paratek Pharmaceuticals announced it will acquire the company in a deal worth $330 million.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Elevation Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELEV#NASDAQ">ELEV</a>) shares dropped 41% to $0.2798 after the company announced the discontinued development of EO-3021.</li>
<li>Shares of Benson Hill, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHIL#NASDAQ">BHIL</a>) were down 42% to $0.3755 after the company filed for Chapter 11 bankruptcy.</li>
<li>Akebia Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKBA#NASDAQ">AKBA</a>) was down, falling 30% to $1.9950 after the company announced the pricing of a $50 million offering of 25 million common shares at $2/share.</li>
</ul>
Commodities In commodity news, oil traded up 1.3% to $68.00 while gold traded up 0.1% at $3,044.60.
Silver traded down 0.6% to $34.015 on Thursday, while copper fell 0.1% to $5.0930.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.47%, Germany's DAX 40 fell 1.43% and France's CAC 40 fell 0.86%. Spain's IBEX 35 Index fell 0.97%, while London's FTSE 100 slipped 0.15%.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with China's Shanghai Composite Index falling 0.51%, Hong Kong's Hang Seng Index dipped 2.23% and India's BSE Sensex gaining 1.19%.
Economics
<ul>
<li>U.S. existing home sales increased by 4.2% from the previous month to an annualized rate of 4.26 million homes in February.</li>
<li>The U.S. current account deficit shrank by 2.0% to $303.9 billion in the fourth quarter, versus a revised deficit of $310.3 billion in the third quarter.</li>
<li>U.S. initial jobless claims increased by 2,000 to 223,000 during the second week of March, compared to market estimates of 224,000.</li>
<li>The Philadelphia Fed Manufacturing Index fell to 12.5 in March from 18.1 in the previous month, versus market estimates of 8.5.</li>
<li>U.S. natural gas stocks increased 9 billion cubic feet in the week ending March 14, compared to market estimates of a 3 billion cubic feet gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44415297/how-to-earn-500-a-month-from-micron-technology-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Micron Technology Stock Ahead Of Q2 Earnings</a></li>
</ul>

Equities

Eurozone

Commodities

Intraday Update

ELEV

WINT

Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase

ProAssurance Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) stock is moving higher on Thursday after the company announced it <a href="https://www.benzinga.com//node/44406751">will be acquired</a> by The Doctors Company, a medical malpractice insurer.
The Details: Under the definitive agreement, The Doctors Company will acquire ProAssurance for $25 per share, representing a 60% premium over the closing price per share on March 18.
The transaction is valued at approximately $1.3 billion. Once completed, the combined company will have assets totaling around $12 billion.
&#8220;Both ProAssurance and The Doctors Company were founded by physicians in response to the medical liability crisis of the 1970s. Both companies have grown over the years by bringing together other physician-founded companies,&#8221; said Ned Rand, ProAssurance&#8217;s President and CEO.
&#8220;This shared history has helped both companies fulfill our shared mission to protect others and given us similar operating philosophies and cultures. Bringing the strengths and capabilities of our companies together now will allow our teams to continue to serve today&#8217;s healthcare providers with the necessary scale and breadth of capabilities.&#8221;
The transaction is expected to close during the first half of 2026, subject to customary closing conditions, including approval by ProAssurance&#8217;s stockholders. The Board of Directors of ProAssurance has already unanimously approved the deal.
Related Link: <a href="https://www.benzinga.com/25/03/44417609/jabil-q2-earnings-beat-estimates-amid-cloud-and-data-center-growth-stock-surges-on-upbeat-outlook">Jabil Q2 Earnings Beat Estimates Amid Cloud And Data Center Growth, Stock Surges On Upbeat Outlook</a>
PRA Price Action: At the time of writing, ProAssurance stock is trading 47.9% higher at $22.92, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Image: via Shutterstock

Movers

What's Going On With ProAssurance Stock Thursday?

U.S. stocks were higher, with the Dow Jones index gaining around 100 points on Thursday.
Shares of Jabil Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) rose sharply during Wednesday's session after the company reported better-than-expected second-quarter financial results and <a href="https://www.benzinga.com/25/03/44417609/jabil-q2-earnings-beat-estimates-amid-cloud-and-data-center-growth-stock-surges-on-upbeat-outlook">raised its FY25 guidance</a>.
Jabil reported second-quarter adjusted earnings per share of $1.94, beating the analyst consensus estimate of $1.83. Quarterly sales of $6.73 billion outpaced the analyst consensus estimate of $6.408 billion.
Jabil shares jumped 5.1% to $146.67 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>ProAssurance Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) shares jumped 47.8% to $22.98 after the company announced it will be acquired by The Doctors Company for $25.00 per share in cash.</li>
<li>ARS Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRY#NASDAQ">SPRY</a>) gained 24.77% to $14.53 following fourth-quarter results.</li>
<li>China Liberal Education Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLEU#NASDAQ">CLEU</a>) shares rose 19.8% to $2.42.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) jumped 19.5% to $36.77.</li>
<li>Capricor Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) rose 13.7% to $13.90 following strong quarterly results.</li>
<li>Titan Machinery Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TITN#NASDAQ">TITN</a>) gained 12.9% to $16.63 following strong quarterly sales.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) gained 9.9% to $193.50 after Piper Sandler upgraded the stock from Neutral to Overweight..</li>
<li>Gambling.com Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAMB#NASDAQ">GAMB</a>) shares rose 9.4% to $13.65 after reporting upbeat quarterly results.</li>
<li>Immunocore Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>) gained 9% to $31.31.</li>
<li>Darden Restaurants, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) rose 7.7% to $202.57 after the company issued FY25 sales guidance above estimates.</li>
<li>QXO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NYSE">QXO</a>) gained 7.4% to $14.02. On Thursday, QXO disclosed entering into a definitive merger agreement to acquire Beacon for $124.35 per share in cash.</li>
<li>Five Below, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) rose 6.8% to $80.73 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.</li>
<li>The Boston Beer Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) gained 4.4% to $228.68. Citigroup analyst Filippo Falorni upgraded Boston Beer from Neutral to Buy and raised the price target from $265 to $280.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/news/earnings/25/03/44415297/how-to-earn-500-a-month-from-micron-technology-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Micron Technology Stock Ahead Of Q2 Earnings</a></li>
</ul>

CAPR

CLEU

CVNA

GAMB

IMCR

SPRY

TITN

Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday

WIIM

ProAssurance shares are trading higher after the company announced it will be acquired by The Doctors Company for $25.00 per share in cash.

<h3>Gainers</h3>
<ul>
<li>ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) stock moved upwards by 48.7% to $23.11 during Thursday's pre-market session. The company's market cap stands at $1.1 billion. </li>
<li>AGM Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGMH#NASDAQ">AGMH</a>) stock moved upwards by 27.77% to $0.09. The company's market cap stands at $3.9 million. </li>
<li>Prestige Wealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWM#NASDAQ">PWM</a>) stock rose 7.82% to $0.55. The company's market cap stands at $17.4 million. </li>
<li>Ryvyl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVYL#NASDAQ">RVYL</a>) shares rose 7.14% to $1.05. The company's market cap stands at $8.7 million. </li>
<li>X Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYF#NYSE">XYF</a>) shares rose 6.61% to $14.03. The company's market cap stands at $665.1 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Forge Global Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRGE#NYSE">FRGE</a>) shares increased by 5.91% to $0.63. The company's market cap stands at $118.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Riverview Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVSB#NASDAQ">RVSB</a>) stock declined by 13.2% to $4.66 during Thursday's pre-market session. The company's market cap stands at $97.7 million. </li>
<li>Lion Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGHL#NASDAQ">LGHL</a>) stock declined by 8.96% to $0.09. The market value of their outstanding shares is at $2.0 million. </li>
<li>F&amp;G Annuities &amp; Life (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FG#NYSE">FG</a>) shares decreased by 8.73% to $39.01. The company's market cap stands at $4.9 billion. </li>
<li>CNFinance Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNF#NYSE">CNF</a>) stock declined by 8.63% to $0.78. The market value of their outstanding shares is at $53.6 million. </li>
<li>Highest Performances (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPH#NASDAQ">HPH</a>) stock declined by 7.34% to $0.15. The market value of their outstanding shares is at $36.3 million. </li>
<li>mF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFI#NASDAQ">MFI</a>) shares decreased by 7.05% to $0.62. The market value of their outstanding shares is at $8.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FRGE

LGHL

RVYL

12 Financials Stocks Moving In Thursday's Pre-Market Session

Shares of Five Below, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter <a href="https://in.benzinga.com/news/earnings/25/03/44406668/five-below-stock-moves-higher-on-q4-earnings-beat">guidance above estimates</a>.
Five Below reported adjusted earnings of $3.48 per share, beating market estimates of $3.38 per share. The company's sales came in at $1.391 billion versus expectations of $1.386 billion.
Five Below shares jumped 11.9% to $84.59 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>SAG Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAG#NASDAQ">SAG</a>) gained 77.8% to $1.20 in pre-market trading after jumping 7% on Wednesday.</li>
<li>OptiNose, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTN#NASDAQ">OPTN</a>) rose 59.3% to $9.56 in pre-market trading. Paratek Pharmaceuticals announced plans to acquire Optinose in a deal worth up to $330 million.</li>
<li>ProAssurance Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) gained 50.6% to $23.41 in pre-market trading after the company announced it will be acquired by The Doctors Company for $25.00 per share in cash.</li>
<li>AGM Group Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGMH#NASDAQ">AGMH</a>) gained 40.3% to $0.1010 in pre-market. AGM Group Holdings announced the receipt of Nasdaq notification regarding minimum bid requirements.</li>
<li>DevvStream Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DEVS#NASDAQ">DEVS</a>) gained 28.7% to $0.4761 in pre-market trading after jumping 8% on Wednesday.</li>
<li>Emerson Radio Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSN#NYSE">MSN</a>) gained 27.2% to $0.56 in pre-market trading.</li>
<li>CIMG Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IMG#NYSE">IMG</a>) gained 21.1% to $0.5812 in pre-market trading after the company announced its subsidiary signed a business cooperation intent agreement with Shanghai Huomao.</li>
<li>IO Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOBT#NASDAQ">IOBT</a>) rose 12.1% to $1.02 in pre-market trading.</li>
<li>Brookdale Senior Living Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKD#NYSE">BKD</a>) rose 8.1% to $6.60 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Zoomcar Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) fell 28.4% to $0.2196 in pre-market trading after the company announced a 1-for-20 reverse stock split.</li>
<li>Akebia Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKBA#NASDAQ">AKBA</a>) shares fell 26.2% to $2.09 in pre-market trading after the company priced its $50 million public offering of 25 million common shares at $2 per share.</li>
<li>Leishen Energy Holding Co., Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LSE#NYSE">LSE</a>) fell 17.1% to $10.37 in pre-market trading after gaining around 66% on Wednesday. Leishen Energy recently reported FY24 financial results.</li>
<li>Riverview Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVSB#NASDAQ">RVSB</a>) declined 13.2% to $4.66 in pre-market trading.</li>
<li>Benson Hill, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHIL#NASDAQ">BHIL</a>) dipped 13.2% to $0.56 in pre-market trading after dipping 15% on Wednesday.</li>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares tumbled 13.2% to $0.0944 in pre-market trading. Virpax Pharmaceuticals shares fell 16% on Wednesday after the company announced a 1-for-25 reverse stock split.</li>
<li>Meihua International Medical Technologies Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHUA#NASDAQ">MHUA</a>) shares fell 12.3% to $0.2884 in pre-market trading.</li>
<li>Maze Therapeutics, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAZE#NASDAQ">MAZE</a>) fell 11.8% to $10.70 in today's pre-market trading.</li>
<li>JOYY Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YY#NASDAQ">YY</a>) shares dipped 10.8% to $41.78 in pre-market trading following weak quarterly sales.</li>
<li>Enerflex Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFXT#NYSE">EFXT</a>) fell 7.1% to $7.00 in pre-market trading after the company reported that Marc Rossiter has stepped down as President, CEO, and Director.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/markets/25/03/44396642/jim-cramer-says-tjx-is-terrific-recommends-buying-these-stocks"> </a>
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44396642/jim-cramer-says-tjx-is-terrific-recommends-buying-these-stocks">Jim Cramer Says TJX Is &#8216;Terrific,&#8217; Recommends Buying These Stocks</a></li>
</ul>
Photo: Shutterstock

Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

ProAssurance Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) shares are soaring in Wednesday&#8217;s after-hours session following the company announcement that it will be <a href="https://www.benzinga.com/pressreleases/25/03/b44405938/the-doctors-company-to-acquire-proassurance-corporation-for-25-00-per-share-in-cash">acquired by The Doctors Company</a>.
What Happened: After market close on Wednesday, ProAssurance announced it entered into a definitive agreement to be acquired by physician-owned medical malpractice insurer The Doctors Company for $25 per share in cash.
The deal has a transaction value of approximately $1.3 billion and represents a 60% premium to ProAssurance&#8217;s stock price at the close on Tuesday. 
&#8220;This transaction will deliver significant value to our shareholders,&#8221; said Ned Rand, president and CEO of ProAssurance.
&#8220;Bringing the strengths and capabilities of our companies together now will allow our teams to continue to serve today&#8217;s healthcare providers with the necessary scale and breadth of capabilities.&#8221;
Check This Out: <a href="https://www.benzinga.com/25/03/44405183/march-madness-2025-how-to-watch-betting-odds-and-the-one-stat-that-could-determine-a-winner">March Madness 2025: How To Watch, Betting Odds And The One Stat That Could Determine A Winner</a>
ProAssurance&#8217;s board unanimously approved the transaction. The deal is expected to close in the first half of 2026. Upon closing, ProAssurance&#8217;s common stock will no longer be listed on the New York Stock Exchange and the company will become a wholly-owned subsidiary of The Doctors Company.
&#8220;Healthcare is a team sport and the teams are getting larger. In order to provide them the best imaginable service requires a mission-based company with nationwide scale, resources and dedication to all medical professions and healthcare providers,&#8221; said Richard Anderson, chairman and CEO of The Doctors Company. 
PRA Price Action: <a href="http://benzinga.com/quote/pra">ProAssurance shares</a> were up 50.13% after-hours, trading at $23.33 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Health Care

After-Hours Center

ProAssurance Stock Jumps 50% On Takeover Deal With The Doctors Company

Addition of ProAssurance Corporation fortifies the promise of The Doctors Company to the medical professional liability market for generations to come
The Doctors Company, the nation&#39;s largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE:<a href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>), an industry-leading specialty insurer with extensive expertise in medical liability, products liability for medical technology and life sciences, and workers&#39; compensation insurance, today announced that they have entered into a definitive agreement under which ProAssurance will be acquired by The Doctors Company. Under the terms of the agreement, ProAssurance stockholders will receive $25.00 in cash per share, representing an approximately 60% premium to the closing price per share of ProAssurance common stock on March 18, 2025, the last trading day prior to today&#39;s announcement, with a transaction value of approximately $1.3 billion. The combined company will have assets of approximately $12 billion.

The Doctors Company To Acquire ProAssurance For ~$1.3B, Or $25.00 Per Share In Cash

U.S. stocks were mixed, with the Dow Jones gaining over 100 points on Tuesday.
Shares of Itron, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRI#NASDAQ">ITRI</a>) rose sharply during Tuesday's session after the company reported <a href="https://www.benzinga.com/quote/ITRI/earnings">better-than-expected fourth-quarter financial results.</a>
Itron posted quarterly earnings of $1.35 per share, beating market estimates of $1.05 per share. The company's quarterly sales came in at $612.864 million beating estimates of $603.204 million.
Additionally, the company issued FY25 EPS guidance above estimates.
Itron shares jumped 9.7% to $101.57 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>AdaptHealth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHCO#NASDAQ">AHCO</a>) shares jumped 25.4% to $10.73 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) gained 20.8% to $24.36 after the company reported better-than-expected fourth-quarter revenue results and issued first-quarter revenue guidance above estimates.</li>
<li>Dream Finders Homes, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFH#NYSE">DFH</a>) gained 19.8% to $25.16 following better-than-expected quarterly financial results..</li>
<li>FARO Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FARO#NASDAQ">FARO</a>) jumped 18.2% to $31.99 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter adjusted EPS guidance above estimates.</li>
<li>Goosehead Insurance, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) gained 16.8% to $123.48 after the company reported better-than-expected quarterly EPS and sales.</li>
<li>ProAssurance Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) jumped 15.4% to $16.28 after the company reported quarterly financial results and beat its adjusted EPS and revenue estimates.</li>
<li>JBT Marel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBTM#NYSE">JBTM</a>) gained 14.7% to $134.57 following fourth-quarter results.</li>
<li>DigitalOcean Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCN#NYSE">DOCN</a>) rose 13.5% to $42.17 after the company reported better-than-expected fourth-quarter results.</li>
<li>Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) gained 13.2% to $29.84 after the company announced first Electric SUV.</li>
<li>Stantec Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STN#NYSE">STN</a>) gained 8.6% to $82.92 following quarterly results.</li>
<li>The Home Depot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) gained 4.5% to $399.58 after the home improvement retailer reported its fourth-quarter 2024 results and provided its 2025 outlook.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43948819/intuit-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Intuit Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

AHCO

DOCN

EVER

FARO

GSHD

ITRI

JBTM

Itron Posts Upbeat Results, Joins AdaptHealth, EverQuote, Goosehead Insurance And Other Big Stocks Moving Higher On Tuesday

Citizens Capital Markets analyst Matthew J. Carletti reiterated the Market Outperform rating on ProAssurance Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>), <a href="https://www.benzinga.com/quote/PRA/analyst-ratings" target="_blank" rel="noreferrer noopener">with a price targe of $20.</a>
The company reported on Monday fourth-quarter results, where net investment income increased 9%. Gross premiums written fell 0.5% to $207.67 million.
Carletti noted the core Specialty P&amp;C segment&#8217;s accident-year loss ratio matched expectations at 83%, reflecting continued caution around loss severity in select jurisdictions, while the Workers&#8217; Compensation segment&#8217;s loss ratio also met expectations at 77%, driven by elevated medical loss trends.
GWP in the core Specialty P&amp;C segment remained flat, in line with estimates, with cautious underwriting amidst a competitive market, solid renewal pricing (+8%), and retention (84%).
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/25/02/43938959/trump-targets-chinas-tech-sector-with-stricter-biden-era-chip-curbs-it-will-backfire-says-beijing" rel="noreferrer noopener">Trump Reportedly Targets China&#8217;s Tech Sector With Stricter Biden-Era Chip Curbs. It Will Backfire, Says Beijing</a>
The analyst wrote Workers&#8217; Compensation GWP rose by 6%, surpassing estimates mainly due to higher audit premiums, though lower new business ($3 million vs. $5 million last year) partially offset the increase.
The analyst observes that as courts cleared post-COVID-19 pandemic backlogs, a surge in large jury verdicts and social inflation emerged, prompting ProAssurance to adopt a &#8220;defense&#8221; strategy, focusing on necessary rate increases to cover elevated loss costs, which could limit near-term growth.
While frequency has declined in its workers&#8217; compensation business, severity persists.
ProAssurance&#8217;s aggressive pricing actions and constrained growth have allowed it to stay ahead of &#8220;loss cost trends,&#8221; resulting in stable loss ratios and favorable PPD levels.
The analyst noted the company was in a stronger, more stable position than a year ago and viewed the current 40%+ discount to book value as an overreaction.
PRA Price Action: ProAssurance shares traded higher by 14.10% to $16.10 at publication Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43945252/lucid-q4-earnings-preview-production-deliveries-margins-on-watch" target="_blank" rel="noreferrer noopener">Lucid Q4 Earnings Preview: Production, Deliveries, Margins On Watch</a></li>
</ul>
Photo: Ground Picture via Shutterstock

Insurance

ProAssurance Takes Defensive Play During Surge Of Jury Verdicts: Analyst

Citizens Capital Markets analyst Karol Chmiel reiterates ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) with a Market Outperform and maintains $20 price target.

Reiteration

Citizens Capital Markets Reiterates Market Outperform on ProAssurance, Maintains $20 Price Target

ProAssurance shares are trading higher after the company reported Q4 financial results and beat its adjusted EPS and revenue estimates.

ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.17 by 111.76 percent. This is a 820 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $241.07 million which beat the analyst consensus estimate of $209.77 million by 14.92 percent. This is a 2.53 percent decrease over sales of $247.33 million the same period last year.

Earnings Beats

ProAssurance Q4 Adj EPS $0.36 Beats $0.17 Estimate, Sales $241.07M Beat $209.77M Estimate

Penny Stocks

Small Cap

Press Releases

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - PRA, KRON, AXL, SWTX

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AXL, KRON, PRA, SWTX on Behalf of Shareholders

$HAREHOLDER NOTICE: The M&A Class Action Firm Continues To Investigate The Merger - PRA, AXL, SWTX and VIGL

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, AXL, SWTX, VIGL on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPOF, PRA, SWTX on Behalf of Shareholders

Mutual Funds

Dividends

ABRDN INCOME CREDIT STRATEGIES FUND 5.25% SERIES A PERPETUAL PREFERRED SHARES DECLARE QUARTERLY DIVIDEND

ProAssurance Stockholders Approve Its Proposed Acquisition by The Doctors Company

The Doctors Company and ProAssurance Announce Early Termination of the Hart-Scott-Rodino Waiting Period

Comments

ProAssurance

Noticias

Últimas noticias sobre ProAssurance (NYSE:PRA) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL